circ-EGFR inhibited the malignant progression of glioma by regulating the levels of miR-183-5p and TUSC2.
Circ-EGFR Functions as an Inhibitory Factor in the Malignant Progression of Glioma by Regulating the miR-183-5p/TUSC2 Axis.